In the world of investing, biotech stocks represent a unique blend of high risk and high reward. After a period of volatility in the broader markets in 2022 and 2023, biotech stocks are now drawing attention for their potential to deliver substantial long-term returns. The global biotechnology market, valued at $1.2 trillion in 2022, is projected to grow to$3.9 trillion by 2031. Key drivers for growth include increasing R&D activities, government funding and rising demand. New biotechnology products can ad ...